MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717 | +116.6% | 23,624 | +1548.6% | 0.00% | 0.0% |
| Q2 2023 | $331 | -4.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $347 | -16.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $416 | -99.6% | 1,433 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $93,000 | -9.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $103,000 | -27.0% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $141,000 | +16.5% | 1,433 | 0.0% | 0.00% | – |
| Q4 2021 | $121,000 | +6.1% | 1,433 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $114,000 | -18.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $140,000 | -16.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $168,000 | +5.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $159,000 | -6.5% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +4.9% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $162,000 | +68.8% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $96,000 | +43.3% | 1,433 | +95.5% | 0.00% | – |
| Q4 2019 | $67,000 | +6.3% | 733 | 0.0% | 0.00% | – |
| Q3 2019 | $63,000 | -18.2% | 733 | 0.0% | 0.00% | – |
| Q2 2019 | $77,000 | -16.3% | 733 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $92,000 | +10.8% | 733 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $83,000 | -47.1% | 733 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $157,000 | – | 733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |